4.7 Article

An electrochemical wearable sensor for levodopa quantification in sweat based on a metal-Organic framework/graphene oxide composite with integrated enzymes

期刊

SENSORS AND ACTUATORS B-CHEMICAL
卷 359, 期 -, 页码 -

出版社

ELSEVIER SCIENCE SA
DOI: 10.1016/j.snb.2022.131586

关键词

Wearable sweat sensor; Parkinson's disease; Enzyme immobilization; Noninvasive drug detection; ZIF-8

资金

  1. National Natural Science Foundation of China [21804007, 21890742]
  2. SZU Top Ranking Project [86000000210]
  3. Shenzhen Stability Support Plan [20200806163622001]
  4. Fundamental Research Funds for the Central Universities [FRF-BY-20-02]

向作者/读者索取更多资源

In this study, a simple, wearable, noninvasive, and portable metal-organic framework (MOF)-based electrochemical sensor was developed for monitoring the concentration of levodopa in sweat, which can serve as a proxy for the levels of L-dopa in the body. The sensor showed a wide linear response range, low detection limit, good selectivity, high sensitivity, and stability.
Levodopa (L-dopa) is an effective medication for Parkinson's disease. However, excess intake from overdose or the intake of natural sources of L-dopa can be dangerous, causing, for example, tardive dyskinesia. Therefore, in medicated individuals, it is important to monitor the levels of L-dopa in the body. In this paper, we report a simple, wearable, noninvasive, and portable metal-organic framework (MOF)-based electrochemical sensor with integrated enzymes for monitoring the concentration of levodopa in sweat, which can be used as a proxy for L-dopa levels in the body. Zeolitic imidazolate framework/graphene oxide (ZIF-8/GO) composites were prepared by the in-situ growth of ZIF-8 nanoparticles on the surface of GO, and, subsequently, tyrosinase was loaded onto the composite to yield the sensor. Integration with a wireless electronic circuit enabled communication between the sensor and a smartphone application for continuous analysis. The sensor was found to have a wide linear response range from 1 to 95 mu M, a low limit of detection of 0.45 mu M, satisfactory reproducibility, and excellent selectivity. In addition, the sensor showed high sensitivity and good stability as a result of the anchoring of the enzyme. Thus, the sensor shows promise for continuous, noninvasive point-of-care drug monitoring and management.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据